The fractional excretion of potassium (FEK) estimates what percentage of the potassium filtered by the kidneys is ultimately excreted in urine. It is calculated from paired blood and urine potassium and creatinine measurements. FEK can help when a potassium abnormality raises the question, “Are the kidneys appropriately conserving potassium, or are they losing too much?” The test is most often used as an adjunct in hypokalemia, but it can also describe kidney potassium handling in hyperkalemia and kidney disease. FEK is not a universal stand-alone diagnostic test. Its value changes with serum potassium, kidney function, urine flow, sodium delivery to the distal nephron, medications, and acid-base status. A result that looks high in a person with normal potassium may have a different meaning in someone with marked hypokalemia. Clinicians therefore interpret FEK beside serum potassium, magnesium, bicarbonate, creatinine, blood pressure, urine potassium, and the medication list.
- FEK estimates renal potassium excretion relative to filtration: it uses simultaneous urine and blood potassium and creatinine.
- During hypokalemia, a low FEK supports appropriate kidney potassium conservation; a clearly elevated FEK supports renal potassium wasting.
- Older data found FEK around 4%–16% in healthy adults, but there is no single universal reference range for every clinical setting.
- Diuretics, kidney disease, high distal sodium delivery, magnesium deficiency, and aldosterone activity can change FEK.
- Severe hypokalemia or hyperkalemia can cause dangerous heart rhythm problems and should be assessed urgently, not interpreted from FEK alone.
Table of Contents
- What FEK Measures and How It Is Calculated
- How to Interpret FEK in Hypokalemia and Hyperkalemia
- Causes of High and Low FEK
- FEK Versus Other Urine Potassium Tests
- Sample Collection, Medications, and Confounders
- What Happens After an Abnormal Result
What FEK Measures and How It Is Calculated
FEK describes the fraction of filtered potassium that appears in the final urine. The calculation is:
FEK (%) = (urine potassium × serum creatinine) ÷ (serum potassium × urine creatinine) × 100
The urine and blood samples should be collected close together because potassium handling can change quickly after fluids, diuretics, potassium replacement, insulin, vomiting, or changes in kidney function.
The logic is similar to other fractional excretion calculations. Creatinine is used as an approximate marker of filtration, while urine and serum potassium show how much potassium is being excreted relative to what is available in the filtered plasma. A urine potassium test provides the raw urine potassium concentration; FEK adds creatinine correction and the serum potassium level.
Potassium handling is unusual because the kidney does more than simply filter and reabsorb it. Most filtered potassium is reabsorbed before the distal nephron. The final amount in urine is then strongly influenced by potassium secretion in the distal nephron and collecting duct. Aldosterone, distal sodium delivery, tubular flow, serum potassium, and acid-base status all affect this secretion.
That physiology explains why FEK is context dependent. If serum potassium is low, a healthy kidney should strongly reduce urinary potassium loss. If serum potassium is high and kidney function is adequate, the kidney should generally increase potassium excretion. The same FEK value can therefore be “appropriate” in one situation and “inappropriately high” or “inappropriately low” in another.
A classic study of healthy adults reported a mean FEK near 8%, with a range of about 4%–16%. In hypokalemic patients with potassium loss from outside the kidneys, the mean was lower, around 2.8%, whereas patients with renal potassium wasting had much higher values. Those figures are useful teaching references, but modern interpretation should not turn them into rigid cutoffs.
How to Interpret FEK in Hypokalemia and Hyperkalemia
The first step is to interpret the serum potassium itself. FEK is secondary.
FEK in hypokalemia
Hypokalemia usually means serum potassium is below about 3.5 mmol/L. When potassium is low, the kidney should conserve it. A low FEK therefore supports an appropriate renal response and makes gastrointestinal losses, poor intake, or a shift of potassium into cells more likely.
A clearly elevated FEK during untreated hypokalemia suggests that the kidneys are continuing to excrete potassium despite the body’s need to conserve it. Causes include diuretics, mineralocorticoid excess, renal tubular disorders, some forms of renal tubular acidosis, and magnesium deficiency.
The key word is untreated. If a patient has already received potassium, saline, or a diuretic, urine potassium handling may no longer reflect the original problem. Timing can change the result substantially.
The serum potassium blood test also needs to be paired with magnesium. Low magnesium can cause persistent renal potassium wasting and make potassium replacement difficult until magnesium is corrected.
FEK in hyperkalemia
With hyperkalemia, a functioning kidney should generally increase potassium excretion. A relatively low FEK may suggest impaired kidney potassium secretion, but FEK is less standardized for this purpose than many clinicians expect.
Low kidney filtration, low urine flow, reduced distal sodium delivery, hypoaldosteronism, aldosterone resistance, and medications that block the renin-angiotensin-aldosterone system can all reduce potassium excretion. Advanced chronic kidney disease also changes the relationship between filtered potassium and tubular secretion, making fractional excretion values harder to compare with those of healthy people.
Hyperkalemia assessment must start with confirmation that the serum result is real. Hemolysis during blood collection, extreme thrombocytosis, or marked leukocytosis can produce pseudohyperkalemia. If the potassium is truly high, electrocardiography and urgent treatment may take priority over urine calculations.
FEK and kidney function
A higher FEK does not necessarily mean the kidneys are “working better.” As nephron number falls, remaining nephrons may increase potassium secretion. FEK can therefore rise in kidney disease as an adaptive response. Recent studies have also examined FEK as a marker in acute kidney injury and nephrotic syndrome, but these are research and prognostic applications rather than established stand-alone diagnostic uses.
The estimated glomerular filtration rate (eGFR) and serum creatinine remain the standard measures for overall filtration.
Causes of High and Low FEK
A high or low FEK should be interpreted against the serum potassium and clinical problem.
| Clinical setting | FEK pattern | Possible explanation |
|---|---|---|
| Hypokalemia | Low FEK | Appropriate renal conservation; consider diarrhea, vomiting after the active loss has stopped, low intake, or intracellular shift |
| Hypokalemia | High FEK | Renal potassium wasting from diuretics, mineralocorticoid effect, tubulopathy, renal tubular acidosis, or magnesium deficiency |
| Hyperkalemia | Low or insufficient FEK | Reduced filtration, low distal sodium delivery, hypoaldosteronism, aldosterone resistance, or potassium-retaining drugs |
| CKD with normal potassium | FEK may be elevated | Adaptive secretion by remaining nephrons |
Diuretics and renal potassium wasting
Loop and thiazide diuretics increase sodium delivery and flow to potassium-secreting segments of the nephron. They can therefore increase urinary potassium loss and FEK. If testing is performed while a diuretic is active, the result may primarily show the medication’s effect.
When diuretic use is known, the question may not be whether the kidneys are wasting potassium, but whether the medication, dose, sodium intake, and magnesium status explain the magnitude of loss.
Aldosterone and blood pressure
Aldosterone increases sodium reabsorption through epithelial sodium channels and promotes potassium secretion. In a hypertensive patient with hypokalemia and renal potassium wasting, clinicians may evaluate renin and aldosterone for primary aldosteronism or other mineralocorticoid states.
In a patient with hyperkalemia and low renal potassium excretion, low aldosterone production or reduced aldosterone effect becomes more relevant. Diabetes, chronic kidney disease, adrenal disease, and medications such as ACE inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, trimethoprim, and some NSAIDs can contribute.
A transtubular potassium gradient (TTKG) has historically been used to estimate distal potassium secretion and aldosterone effect, but its physiologic assumptions and reliability are debated. FEK is easier to calculate, yet it also cannot identify the cause of abnormal potassium handling by itself.
Renal tubular disorders and acid-base status
Bartter and Gitelman syndromes can produce renal salt wasting, metabolic alkalosis, and hypokalemia. Distal and proximal tubular disorders can also affect potassium. Urine chloride, magnesium, calcium, blood pressure, renin, aldosterone, and bicarbonate often help separate these conditions.
Metabolic acidosis changes the differential diagnosis. Diarrhea can cause both bicarbonate and potassium loss outside the kidney, while renal tubular acidosis can cause inappropriate renal losses. A bicarbonate blood test is therefore commonly part of the workup.
FEK Versus Other Urine Potassium Tests
FEK is one way to assess renal potassium handling, not automatically the best one.
Spot urine potassium concentration is simple, but it is affected by how dilute the urine is. A low concentration can occur in a very dilute sample even when total potassium excretion is substantial.
Urine potassium-to-creatinine ratio adjusts for urine concentration and can be useful in a spot sample. It is often easier to interpret than raw urine potassium when a 24-hour collection is impractical.
24-hour urine potassium estimates total daily excretion. It can be useful when potassium intake and losses are relatively stable, but collection errors are common. Potassium excretion also changes rapidly during an acute disorder, so a 24-hour average may blur the physiology that is most relevant at a specific moment.
TTKG attempts to estimate potassium concentration in the cortical collecting duct after correcting for water reabsorption. It requires urine and plasma osmolality and depends on assumptions that may not hold in many patients.
FEK has two practical advantages: it uses commonly available measurements and incorporates both serum potassium and creatinine correction. Its disadvantage is that no single threshold cleanly separates every cause of hypo- or hyperkalemia.
In complex cases, clinicians often use several clues together rather than choosing one “winner.” The pattern of urine potassium, urine creatinine, urine sodium or chloride, serum magnesium and bicarbonate, blood pressure, and medication exposure usually provides more information than FEK alone.
Sample Collection, Medications, and Confounders
FEK requires a spot urine potassium and creatinine plus serum potassium and creatinine. Samples should be obtained as close together as practical.
No special fasting is usually required, but the ordering clinician may want the sample before potassium replacement, IV fluids, or the next diuretic dose. Do not delay urgent treatment simply to obtain a “clean” FEK measurement.
Important confounders include:
- potassium supplements or recent IV potassium;
- loop or thiazide diuretics;
- ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, amiloride, and triamterene;
- corticosteroids or mineralocorticoid therapy;
- insulin, beta-agonists, and acid-base shifts that move potassium between cells and blood;
- low magnesium;
- rapidly changing kidney function;
- very low urine output;
- high or low sodium intake.
Urine creatinine also depends partly on muscle mass and urine concentration. In frail people with very low creatinine generation, or in rapidly changing kidney failure, the creatinine-based correction may be less reliable.
A broader renal function panel can provide serum electrolytes, bicarbonate, creatinine, and related measurements needed to understand the overall pattern.
What Happens After an Abnormal Result
An abnormal FEK does not lead to one fixed next test. Follow-up is driven by the serum potassium and suspected mechanism.
For hypokalemia with renal potassium wasting, clinicians commonly review diuretics and laxatives, measure magnesium and bicarbonate, assess blood pressure, and consider urine chloride. Renin and aldosterone may be appropriate when mineralocorticoid excess is suspected. Persistent findings can lead to evaluation for inherited or acquired tubulopathies.
For hyperkalemia with inadequate renal potassium excretion, the clinician usually reviews kidney function and medications first. Diabetes and CKD can reduce renin and aldosterone signaling. Adrenal insufficiency is considered when compatible symptoms, sodium abnormalities, blood pressure findings, or endocrine risk factors are present.
Potassium urgency is determined by the serum level, rate of change, symptoms, kidney function, and ECG—not by FEK. Severe muscle weakness, paralysis, palpitations, syncope, chest symptoms, or a markedly abnormal potassium result warrants urgent medical evaluation. Hyperkalemia can be dangerous even without symptoms, and severe hypokalemia can provoke ventricular arrhythmias.
The most useful way to read FEK is as a kidney-response test. Ask whether urinary potassium handling is appropriate for the current serum potassium. Then use blood pressure, acid-base status, magnesium, kidney function, urine electrolytes, and medication exposure to identify why that response is occurring.
Practical FEK interpretation examples
FEK is most useful when the clinical question is explicit: Should the kidneys be conserving potassium or excreting it? The same FEK value can be appropriate in one patient and inappropriate in another.
Hypokalemia with a low FEK: If serum potassium is 2.9 mmol/L and FEK is around 2%–3%, the kidney is strongly conserving potassium. That makes an ongoing extrarenal loss, low intake, or a recent intracellular shift more likely than primary renal potassium wasting. Diarrhea is a common example. The history, acid-base pattern, and magnesium level still matter because the potassium loss may have occurred earlier and stopped before testing.
Hypokalemia with a clearly elevated FEK: If serum potassium is low but FEK remains around 10%–15% or higher, urinary loss is inappropriate for the serum state. Diuretics, mineralocorticoid excess, renal tubular disorders, magnesium deficiency, and some drug effects become more important possibilities. A urine chloride, blood pressure pattern, bicarbonate, renin, and aldosterone may help separate them.
Hyperkalemia with a low FEK: When serum potassium is high, the kidney should normally increase potassium secretion. A low FEK can support impaired renal potassium elimination, but reduced GFR, low distal sodium delivery, low aldosterone activity, and medications may all contribute. This is one reason FEK does not diagnose hypoaldosteronism by itself.
Hyperkalemia with a higher FEK: A relatively high FEK suggests that the kidneys are attempting to excrete potassium. Hyperkalemia may then reflect a potassium load, cell breakdown, redistribution out of cells, or a reduction in filtration that overwhelms an otherwise active secretory response. The absolute amount of potassium excreted still depends on urine flow and filtered load.
FEK changes with kidney function
Because FEK uses creatinine as a filtration marker, the percentage tends to rise as kidney function declines. With fewer functioning nephrons, each remaining nephron may excrete a larger fraction of the delivered potassium even when total daily potassium excretion is not high. A percentage that would look high in a person with normal GFR can therefore be less surprising in advanced chronic kidney disease.
This effect is important when applying older reference ranges. The classic study that reported a mean FEK near 8% in healthy people and lower values during appropriate potassium conservation was performed in a different population from many modern hospitalized patients. Critical illness, AKI, CKD, diuretics, and rapid treatment can all change the relationship between FEK and whole-body potassium balance.
Avoid interpreting FEK in isolation
A potassium disorder should always be confirmed with the serum result and, when clinically appropriate, an ECG. Acid-base status can narrow the differential. Metabolic alkalosis with renal potassium loss suggests a different group of causes from non-anion-gap metabolic acidosis with renal potassium loss. Magnesium deficiency can make hypokalemia difficult to correct because it promotes renal potassium wasting.
Timing is also crucial. A urine sample collected after potassium replacement, IV fluids, insulin, a diuretic dose, or a change in mineralocorticoid therapy may not represent the physiology that produced the original abnormal serum potassium. If the result seems inconsistent, reviewing the treatment timeline is often more informative than applying a rigid cutoff.
FEK is therefore best viewed as a physiologic clue. It can demonstrate whether renal potassium handling is broadly appropriate for the serum potassium, but diagnosis usually comes from combining that clue with urine flow, kidney function, acid-base findings, blood pressure, medication exposure, and—when indicated—renin and aldosterone measurements.
References
- Fractional excretion of potassium in normal subjects and in patients with hypokalaemia 1995
- Renal Hypokalemia: An Endocrine Perspective 2024 (Review)
- Pathophysiology and clinical management of hyperkalemia in chronic kidney disease 2023 (Review)
- Association between Urinary Fractional Excretion of Potassium and Proteinuria Remission in Adult Nephrotic Syndrome 2026
- Urinary electrolyte parameters in sepsis-associated acute kidney injury: A prospective observational study 2025
- Extrarenal Effects of Aldosterone on Potassium Homeostasis 2022 (Review)
Disclaimer
FEK is an adjunctive calculation and cannot determine the cause or urgency of a potassium disorder by itself. Potassium abnormalities can become life-threatening, so treatment decisions should be based on serum potassium, symptoms, ECG findings, kidney function, medications, and clinical assessment. Do not stop prescribed potassium-related medicines based only on a urine calculation.
